LBP-1 (médicament) (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "LBP-1 (médicament)" in French language version.

refsWebsite
Global rank French rank
4th place
12th place
2nd place
3rd place

doi.org

dx.doi.org

  • « Design, synthesis, and structure-activity relationships of indole-3-heterocycles as agonists of the CB1 receptor », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 1,‎ , p. 506–9 (PMID 21075630, DOI 10.1016/j.bmcl.2010.10.093)
  • « Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 6,‎ , p. 1748–53 (PMID 21316962, DOI 10.1016/j.bmcl.2011.01.082)
  • « Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 8,‎ , p. 2541–6 (PMID 21411321, DOI 10.1016/j.bmcl.2011.02.023)
  • « Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain », Bioorganic & Medicinal Chemistry Letters, vol. 22, no 8,‎ , p. 2932–7 (PMID 22421020, DOI 10.1016/j.bmcl.2012.02.048)

nih.gov

ncbi.nlm.nih.gov

  • « Design, synthesis, and structure-activity relationships of indole-3-heterocycles as agonists of the CB1 receptor », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 1,‎ , p. 506–9 (PMID 21075630, DOI 10.1016/j.bmcl.2010.10.093)
  • « Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 6,‎ , p. 1748–53 (PMID 21316962, DOI 10.1016/j.bmcl.2011.01.082)
  • « Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate », Bioorganic & Medicinal Chemistry Letters, vol. 21, no 8,‎ , p. 2541–6 (PMID 21411321, DOI 10.1016/j.bmcl.2011.02.023)
  • « Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain », Bioorganic & Medicinal Chemistry Letters, vol. 22, no 8,‎ , p. 2932–7 (PMID 22421020, DOI 10.1016/j.bmcl.2012.02.048)